BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Leen E, Kumar S, Khan SA, Low G, Ong KO, Tait P, Averkiou M. Contrast-enhanced 3D ultrasound in the radiofrequency ablation of liver tumors. World J Gastroenterol 2009; 15(3): 289-299 [PMID: 19140228 DOI: 10.3748/wjg.15.289] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Chan VS, Mohamed F, Yusoff YA, Dewi DEO, Anuar A, Shamsudin MA, Mong WS. Using game controller as position tracking sensor for 3D freehand ultrasound imaging. Med Biol Eng Comput 2020;58:889-902. [DOI: 10.1007/s11517-019-02044-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Kim TK, Lee KH, Khalili K, Jang H. Hepatocellular nodules in liver cirrhosis: contrast-enhanced ultrasound. Abdom Imaging 2011;36:244-63. [DOI: 10.1007/s00261-011-9686-0] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 3.9] [Reference Citation Analysis]
3 Hoyt K, Sorace A, Saini R. Quantitative mapping of tumor vascularity using volumetric contrast-enhanced ultrasound. Invest Radiol 2012;47:167-74. [PMID: 22104962 DOI: 10.1097/RLI.0b013e318234e6bc] [Cited by in Crossref: 59] [Cited by in F6Publishing: 28] [Article Influence: 5.9] [Reference Citation Analysis]
4 Menu Y. Imagerie du foie. Gastroentérologie Clinique et Biologique 2009;33:882-95. [DOI: 10.1016/j.gcb.2009.06.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
5 Goh V, Sarker D, Osmany S, Cook GJ. Functional imaging techniques in hepatocellular carcinoma. Eur J Nucl Med Mol Imaging. 2012;39:1070-1079. [PMID: 22434049 DOI: 10.1007/s00259-012-2096-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
6 Lin SM. Local ablation for hepatocellular carcinoma in taiwan. Liver Cancer 2013;2:73-83. [PMID: 24159599 DOI: 10.1159/000343843] [Cited by in Crossref: 26] [Cited by in F6Publishing: 38] [Article Influence: 3.3] [Reference Citation Analysis]
7 Xiang H, Huang R, Cheng J, Gulinaer S, Hu R, Feng Y, Liu H. Value of three-dimensional contrast-enhanced ultrasound in the diagnosis of small adnexal masses. Ultrasound Med Biol 2013;39:761-8. [PMID: 23453372 DOI: 10.1016/j.ultrasmedbio.2012.11.008] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
8 Wang Y, Jing X, Ding J. Clinical value of dynamic 3-dimensional contrast-enhanced ultrasound imaging for the assessment of hepatocellular carcinoma ablation. Clinical Imaging 2016;40:402-6. [DOI: 10.1016/j.clinimag.2015.11.022] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
9 Hoogenboom TC, Thursz M, Aboagye EO, Sharma R. Functional imaging of hepatocellular carcinoma. Hepat Oncol 2016;3:137-53. [PMID: 30191034 DOI: 10.2217/hep-2015-0005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
10 Zhang W, Luo E, Gan J, Song X, Bao Z, Zhang H, Chen M. Long-term survival of hepatocellular carcinoma after percutaneous radiofrequency ablation guided by ultrasound. World J Surg Oncol 2017;15:122. [PMID: 28679433 DOI: 10.1186/s12957-017-1189-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
11 Bartolotta TV, Taibbi A, Matranga D, Midiri M, Lagalla R. 3D versus 2D contrast-enhanced sonography in the evaluation of therapeutic response of hepatocellular carcinoma after locoregional therapies: preliminary findings. Radiol Med. 2015;Epub ahead of print. [PMID: 25698299 DOI: 10.1007/s11547-015-0514-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 2.9] [Reference Citation Analysis]
12 Wahba R, Bangard C, Kleinert R, Rösgen S, Fischer J, Lackner K, Hölscher AH, Stippel DL. Electro-physiological parameters of hepatic radiofrequency ablation—a comparison of an in vitro versus an in vivo porcine liver model. Langenbecks Arch Surg 2009;394:503-9. [DOI: 10.1007/s00423-009-0475-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
13 Chan AK, Hegarty C, Klass D, Yoshida E, Chung S, Liu DM, Ho SG, Harris AC. The Role of Contrast-Enhanced Ultrasound in Guiding Radiofrequency Ablation of Hepatocellular Carcinoma. Can Assoc Radiol J 2015;66:171-8. [DOI: 10.1016/j.carj.2014.11.005] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
14 Monsky W, Keravnou C, Averkiou M. Contrast-enhanced ultrasound to ultrasound fusion during microwave ablation: feasibility study in a perfused porcine liver model. J Ultrasound 2019;22:323-35. [PMID: 30811016 DOI: 10.1007/s40477-019-00366-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
15 Liu Z, Wang X, Xing L, Pan Y, Huang S. The Application Comparison of Contrast-Enhanced Ultrasound and Contrast-Enhanced Computed Tomography in Radiofrequency Ablation Treatment for Hepatocellular Carcinoma. Cancer Biother Radiopharm 2019;34:621-5. [PMID: 31809215 DOI: 10.1089/cbr.2019.2845] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
16 Streeter JE, Gessner RC, Tsuruta J, Feingold S, Dayton PA. Assessment of Molecular Imaging of Angiogenesis with Three-Dimensional Ultrasonography. Mol Imaging 2011;10:7290.2011.00015. [DOI: 10.2310/7290.2011.00015] [Cited by in Crossref: 28] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
17 Bartolotta TV, Taibbi A, Midiri M, Lagalla R. Contrast-enhanced ultrasound of hepatocellular carcinoma: where do we stand? Ultrasonography 2019;38:200-14. [PMID: 31006227 DOI: 10.14366/usg.18060] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
18 Künzli BM, Abitabile P, Maurer CA. Radiofrequency ablation of liver tumors: Actual limitations and potential solutions in the future. World J Hepatol 2011; 3(1): 8-14 [PMID: 21307982 DOI: 10.4254/wjh.v3.i1.8] [Cited by in Crossref: 65] [Cited by in F6Publishing: 52] [Article Influence: 5.9] [Reference Citation Analysis]
19 Correas JM, Low G, Needleman L, Robbin ML, Cosgrove D, Sidhu PS, Harvey CJ, Albrecht T, Jakobsen JA, Brabrand K. Contrast enhanced ultrasound in the detection of liver metastases: a prospective multi-centre dose testing study using a perfluorobutane microbubble contrast agent (NC100100). Eur Radiol. 2011;21:1739-1746. [PMID: 21479856 DOI: 10.1007/s00330-011-2114-6] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.4] [Reference Citation Analysis]